Compounds > rofecoxib
Page last updated: 2024-11-04

rofecoxib and Epstein-Barr Virus Infections

rofecoxib has been researched along with Epstein-Barr Virus Infections in 1 studies

Epstein-Barr Virus Infections: Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vincent, S1
Slease, RB1
Rocca, PV1

Other Studies

1 other study available for rofecoxib and Epstein-Barr Virus Infections

ArticleYear
Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?
    Delaware medical journal, 2002, Volume: 74, Issue:12

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Drug Interactions; Ep

2002